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Introduction: Noncommunicable diseases (NCDs) are the leading cause of morbidity and
mortality in the Association of Southeast Asian Nations (ASEAN) member states. Progress
has been slow despite the World Health Organization action plan for the prevention and
control of NCDs in the region. This paper presents recommendations focused on practical
strategies for optimizing NCD management in the ASEAN region.
Methods: A multidisciplinary group of experts from six ASEAN member states convened
for two face-to-face meetings to discuss barriers and possible recommendations for optimiz-
ing NCD management, focused on cardiovascular diseases and mental disorders, in the
region. Multiple approaches, ie, analysis of insights from the meetings and a review of
existing literature on NCD programs in the ASEAN region were followed. The proposed
recommendations were also based on selected successful interventions in ASEAN member
states, thus providing actionable strategies.
Results: The gaps identified in NCD management for cardiovascular diseases and mental
disorders in the ASEAN region were classified into gaps relating to policies and to clinical
and public health practice. The proposed solutions addressing policy gaps include fostering
multisectoral public–private partnerships, employing “whole-of-government” and “whole-of-
society” approaches and promoting “health-in-all policies approach” to manage issues with
financing, accessibility, efficiency and quality of health services. Whereas proposed solutions
to bridge clinical and public health practice gaps entail strengthening primary care services,
building the capacity of trained healthcare workers and employing collaborative care for
holistic management of patients.
Conclusion: The scale of premature and preventable deaths from NCDs in the ASEAN
region remains a serious public health concern and requires a “whole-of-system approach”.
The interventions proposed in this paper build on regional collaborations and knowledge
sharing to help develop a concerted and targeted response to NCDs.
Keywords: cardiovascular disease, mental health, prevention strategies, public health
Introduction
In Southeast Asian region, noncommunicable diseases (NCDs) are the leading
cause of mortality, accounting for an estimated 62% (8.5 million) of all deaths;
approximately 50% of these deaths occur in people under 70 years of age.1 Four
major NCDs, ie, cardiovascular diseases (CVDs), diabetes, cancers and chronic
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respiratory diseases contribute to more than 80% of NCD-
related premature deaths. Mental disorders are the fifth
leading contributor of NCD burden and frequently co-
occur with the four major NCDs.2 Overall, NCDs account
for 44% of total disability-adjusted life years (DALYs) in
Southeast Asian countries with mental disorders constitut-
ing the largest proportion (27%) (Table 1).3,4
The Association of Southeast Asian Nations (ASEAN) is
a regional organization comprised of 10 member countries
from the Southeast Asian region (Brunei Darussalam,
Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar,
Philippines, Singapore, Thailand, and Vietnam). The scale
of premature and preventable deaths from NCDs in the
ASEAN region remains a serious public health concern
requiring a “whole-of-system approach”—warranting
response not only from doctors and allied healthcare profes-
sionals, but also policy makers, educators, private sector and
society at all stages along the continuum of care.
Burden of NCDs
Southeast Asian countries face a triple burden of disease—
the backlog of communicable diseases, maternal mortality,
and undernutrition; the emerging challenges from NCDs;
and the consequences of industrialization and globalization,
eg, climate change.5 The triple burden of disease in the
region is further compounded by a demographic transition
into an ageing population.6 Urbanization and globalization
in the Southeast Asian region have brought about a rapid
change in lifestyle-related NCD risk factors including
unhealthy diet and physical inactivity.6,7 The prevalence of
the underlying risk factors of NCDs across all ASEAN
member states is presented in Table 2.8 Among these shared
and preventable risk factors, tobacco use is the leading cause
of NCD-related deaths and its prevalence ranged from 15–
39% in the ASEAN region in 2016.8,9
The microeconomic burden from NCDs is exerted
directly through loss of productivity encompassing the intan-
gible cost of caregiver burden and indirectly through out-of-
pocket expenditure on medical care.6 In Asia, the costs of
managing NCDs burden governments and have disastrous
consequences on patients and their families.10 At the macro-
economic level, the cost of inaction on NCDs in low- and
middle-income countries (LMICs), is estimated at USD 7
trillion between 2011 and 2025.11,12 Between 2011 and 2030,
mental disorders will cost USD 16 trillion in lost economic
output globally—more than cancer, diabetes and respiratory
diseases combined.12 The direct economic losses from CVD
and diabetes combined in Myanmar, Indonesia, Philippines,
Thailand, and Vietnam were estimated at USD 7 billion
between 2006 and 2015.6,13 In light of this epidemiologic
and economic burden, the World Health Organization
(WHO) has identified a number of policy actions, the most
cost-effective interventions and other recommended ser-
vices, collectively termed as “Best buys”, to assist member
states toward achieving reduction in premature mortality
from NCDs.14 “Best buys” are interventions that offer the
optimum mix of policies and actions needed to address the
problem of NCDs. The projected cost of implementing a full
array of these “Best buys” across all LMICs is USD
170 billion;11,12 however, data on the effectiveness of these
best buys in LMICs is limited.15
Healthcare Systems in ASEAN Member
States
The vast economic and sociocultural heterogeneity within the
ASEAN region leads to disparities between the national capa-
cities for NCD control (Table 3).8,16–19 This, combined with
diverse health systems and healthcare financing structures in
individual ASEAN member states, (Figure 1) contributes to
disparate universal health coverage (UHC) in the region.17,20
Malaysia, Singapore and Thailand provide health care cover-
age to all citizens with some form of government-subsidized
health financing schemes.21 Indonesia achieved complete
UHC in 2019, whereas the healthcare coverage in the
Philippines (76%), and Vietnam (82%) remained
suboptimal.21–23 Despite the diversity in healthcare systems,
regional and international collaborations are essential to over-
come healthcare challenges in Southeast Asian countries as
witnessed by recent infectious disease epidemics in the
region.24 Similar collaborative strategies are needed to
strengthen healthcare systems in the ASEAN region to deliver
the NCD continuum-of-care and empower patients, families
and communities.25
Some studies have previously proposed strategies for
NCD management in Southeast Asian countries.6,26,27 Lim
et al reported 12 innovative solutions for NCD management
from ASEAN region.26 Dans et al proposed strategies for
NCD control in Southeast Asian countries based on global
and regional action plans.6 Ezzati et al reported strategies for
effective interventions for NCDs in LMICs.27 Despite these
efforts, and a WHO action plan for prevention and control of
NCDs in Southeast Asian region, progress has been slow in all
ASEAN member states except Singapore.28 This underscores
the need for a regional response built on existing alliances and
knowledge sharing for a concerted action plan towards NCDs.
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Scope of the Study
This paper presents recommendations from a multidisci-
plinary group of experts from six ASEAN member states
for optimizing NCD management in the region. The
recommendations focus on practical strategies for action
supported by successful case studies from the region. This
paper focuses on CVD and mental disorders, as they are
the leading causes of NCD-related mortality and disability
in the region, respectively.1,3
Methods
Data Collection
Amultidisciplinary group (n=83) of healthcare professionals
(HCPs) including a health social scientist from the ASEAN
region met at a seminar workshop in August 2019 to discuss
barriers and possible recommendations for optimizing NCD
management in the region, focused on CVD and mental
health disorders. The meeting aimed to highlight the rising
NCD burden, share current best practices in NCD manage-
ment, identify gaps to improve NCD outcomes and propose
novel initiatives to address these gaps. The multidisciplinary
participants comprised specialists (cardiologists, nephrolo-
gists, psychiatrists, and geriatric physicians), general practi-
tioners (GPs), nurse specialists, pharmacists, nutritionists,
epidemiologists, and public health advocates from six
ASEAN member states: Indonesia (14), Malaysia (13),
Philippines (13), Singapore (15), Thailand (13) and
Vietnam (15). A subgroup of HCPs (n=14); Indonesia (2),
Malaysia (2), Philippines (4), Singapore (1), Thailand (2),
Vietnam (2) and Australia (1) from the first meeting con-
vened for a second face-to-face meeting in November 2019
to further refine the recommendations. Multiple approaches
including an analysis of insights from the two meetings and
a review of existing literature on NCD-related programs in
the ASEAN region were followed in this study.
Data Analysis and Data Validation
Insights were gathered during the seminar-workshop meet-
ing using Workmat® methodology—a poster-based exercise
to maximize interaction between participants to reach con-
clusions on a specific topic.29 The insights were analyzed
qualitatively using a thematic analysis approach to identify
major themes relating to gaps in NCD management
(Supplementary Figure 1).30 Next, the recommendations
comprising recommended action(s), potential stakeholders
Table 1 Burden of NCDs in Selected ASEAN Member Statesa in
2017
Death
(n)
Disabilityb
(Years)
Cardiovascular diseases 4.2 million 6.6 million
Chronic respiratory diseases 1.5 million 13.7 million
Cancer 1.6 million 0.9 million
Diabetes and chronic kidney disease 0.8 million 12 million
Mental disorders 0.06 millionc 32 million
Notes: Data from Institute for Health Metrics and Evaluation, GBD Compare.4
aData are for the following selected ASEAN countries: Indonesia, Malaysia,
Philippines, Singapore, Thailand, and Vietnam. bDisability is measured as disability-
adjusted life years (DALYs). cDeath from mental disorders, suicide and self-harm
(excluding mortality from comorbid NCDs in people with mental disorders).
Abbreviations: ASEAN, Association of Southeast Asian Nations; NCDs, noncom-
municable diseases.
Table 2 Prevalence of Behavioral and Metabolic NCD Risk Factors in the ASEAN Member States
Current
Tobacco
Smoking,
Aged ≥15
Years
Insufficient
Physical
Activity, Aged
≥18 Years
Mean Population Salt/
Sodium Intake, Aged
≥20 Years (g/day)
Total Alcohol/Capita
Consumption, Aged ≥15
Years (Liters of Pure
Alcohol)
Raised Blood
Pressure,
Aged ≥18
Years
Obesity
(Aged ≥18
Years, Aged
10–19
Years)
Raised Blood
Glucose,
Aged ≥18
Years
Brunei
Darussalam
17% 26% 11 0 18% 15%,12% 9%
Cambodia 15% 10% 11 7 23% 4%, 3% 6%
Indonesia 39% 22% 9 1 22% 7%, 5% 7%
Lao PDR 27% 15% 11 10 19% 5%, 4% 6%
Malaysia 22% 38% 9 1 21% 15%, 11% 10%
Myanmar 20% 10% 11 5 23% 6%, 3% 7%
Philippines 24% 38% 11 7 19% 6%, 3% 6%
Singapore 16% 38% 13 2 17% 7%, 6% 9%
Thailand 21% 25% 13 8 25% 11%, 10% 10%
Vietnam 23% 25% 12 8 22% 2%, 2% 5%
Note: Data from the World Health Organization.8
Abbreviations: ASEAN, Association of Southeast Asian Nations; BMI, body mass index; NCD, noncommunicable diseases.
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and performance indicators proposed during the workshops
were compared and categorized under the appropriate
theme. Further, case studies of NCD interventions imple-
mented either at local or national level in the six ASEAN
member states and shared at the seminar-workshop, at the
subsequent face-to-face meeting, or during the development
of this paper were organized under the appropriate theme
and recommendation. The current status and influence of the
case studies on policy, clinical practice and public health
program were confirmed by contacting an appropriate coun-
try point-of-contact. Finally, the recommendations were
individually ranked by each expert, who are authors in this
paper, in terms of its priority for NCD control in the ASEAN
region. Consensus on the recommendations and the case
studies included in this paper was reached following debates
and exchange of information by the experts during and
following the two face-to-face meetings.
Results
Gaps identified in NCD management in ASEAN member
states, in relation to CVD and mental health disorders,
were classified under two main themes: one relating to
policies and the other relating to clinical and public health
practice. The proposed recommendations for addressing
these gaps were arranged under the appropriate themes
(Tables 4 and 5) and further supplemented with the rele-
vant case studies from the region.
Theme 1: Addressing NCD Policy Gaps in
the ASEAN Region
Implement National NCD Screening Programs by
Providing Adequate Resources (Healthcare Facilities
and Trained Health Workers)
Regional Context
Metabolic risk factors such as raised blood pressure (BP),
high body mass index (BMI) or waist-to-hip ratio, elevated
blood sugar levels and abnormal serum lipid concentra-
tions contribute largely to the global NCD burden.31–34
These risk factors have similar effects across Asian and
other populations.35 To reduce morbidity and premature
mortality from NCDs, all WHO member countries have
adopted global targets for select NCD risk factors (tobacco
and alcohol use, salt intake, obesity, and raised levels of
BP and glucose). Achieving these targets is expected to
delay more than 31 million deaths in LMICs from the four
major NCDs between 2020 and 2025.36Ta
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Case Study
In 2011, Malaysia had the highest prevalence of NCD risk
factors (diabetes, 15%; hypertension, 32%; hypercholester-
olemia, 35%; obesity, 15%) among the ASEAN member
states.37 In 2013, the Ministry of Health in collaboration
with other government agencies implemented Komuniti
Sihat Perkasa Negara (KOSPEN), a grassroot-level commu-
nity program, across Malaysia to increase the coverage of
NCD risk factor interventions.37 Under KOSPEN, commu-
nity volunteers (“health agents of change”) were trained to
drive health promoting activities, policy advocacy, NCD risk
factor screening, clinic referrals and other health promoting
intervention programs. KOSPEN also contributes to an
enhanced primary healthcare project, which undertakes
chronic disease screening at the community level, implemen-
tation of patient-centered care at health clinics and referral of
at-risk patients. In 2019, there were 6018 KOSPEN localities
and 36,000 trained volunteers, and over one million adults
screened for NCD risk factors.37 Overall, KOSPEN has been
implemented well and is perceived positively by all
stakeholders.38 The majority of KOSPEN implementors
and volunteers demonstrated a high level of knowledge
about the core activities, awareness of their roles and respon-
sibility and acceptance of the program.39 The program
has a high level of awareness among the community
with approximately 45% participating in the KOSPEN
activities.38
Improve Access to NCD Medications
Regional Context
Availability of medicines is consistently lower in public sector
facilities vs private sector and in LMICs vs higher-income
countries.40 Despite limited efficacy data, high proportion of
population in ASEAN member states use traditional, comple-
mentary, and alternativemedicines for chronic conditions such
as cancer and diabetes.41 Providing equitable access to quality
NCD medications in developing countries needs a focus on
supply chain efficiency, regulatory requirement harmonization
and primary care.40 Improving delivery provisions and exist-
ing medication usage outweighs the benefits from developing
new compounds toward improving access.42
Case Study
In the Philippines, there are around 12 million people with
hypertension.43 The cost of medicines remains high in com-
parison by international standards and a large proportion of
the direct medical costs for hypertension and CVD fall on the
patient in the form of out-of-
pocket payments.44 Therefore, the Philippine government
planned to subsidize outpatient pharmaceuticals for diseases
including hypertension through PhilHealth.44 In 2016, the
Philippines Department of Health launched the
“Hypertension and Diabetes Club” program to provide free
maintenance medicines for hypertension and diabetes to
patients diagnosed using the Philippine Package of
Figure 1 Structure of health expenditure in selected ASEAN member states in 2017.
Note: Data from the World Health Organization.17
Abbreviation: ASEAN, Association of Southeast Asian Nations.
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Table 4 Proposed Recommendations for Addressing Gaps in Policies for Optimizing NCD Management in the ASEAN Member States
Recommended Actions Potential Stakeholders Performance Indicators
1. Implement national NCD
screening programs by pro-
viding adequate resources
(healthcare facilities and
trained health workers)
● Conduct annual/biannual screening—a
minimum of BMI, BP, blood sugar,
blood lipid measurements as defined
by existing clinical practice guidelines
in the country
● Train community volunteers as auxili-
ary healthcare workers
Government, healthcare volunteers,
nonprofit organizations, HCPs and
community
● Proportion of eligible population
screened per year
2. Improve access to NCD
medication
● Regulate to ensure general availability
of NCD medicines and basic technol-
ogies at public and private primary
care centers through UHC or health
insurance
● Increase availability of cost-effective
NCD interventions and quality low-
cost generics in the basic primary
healthcare package
● Explore evidence-based and viable
health-financing mechanisms and inno-
vative economic tools
Government, payers, pharmaceutical
organizations, pharmacies, technology
companies, HCPs and society
● Access and availability of essential
NCD medications including qual-
ity low-cost generics and tech-
nologies in private and public
healthcare facilities
● Population covered by UHC or
other forms of health insurance
3. Introduce health promotion
programs in schools, universi-
ties, workplaces and public/
private spaces
● Organize NCD risk factor awareness
programs
● Introduce school and work-based meal
programs with healthy and balanced
diet
Government, education institutions,
nonprofit organizations, nutrition experts
and society
● Incidence of diabetes, hyperten-
sion and obesity in the population
4. Pass and implement legislation
to reduce NCD risk factors
(tobacco use, excessive alco-
hol use and salt intake)
● Increase taxes on tobacco and alcohol
● Implement salt tax on food processing
industry
● Ban use of trans-fat in processed food
Government, civil society, nonprofit
organizations, tobacco industry, food
industry, private sector and academia
● Trend in number of smokers
● Trend in average alcohol
consumption
● Salt intake <5 g/day (measured by
dietary record or urinary sodium
excretion) in the adult population
5. Provide an encouraging physi-
cal and social environment for
people to practice healthy
habits and incentivize healthy
lifestyle
● Create smoke-free areas in cities
● Improve pedestrian and bicycle net-
work infrastructure across city
● Increase green, open and safe spaces in
cities
● Reduce air pollution
● Provide incentive-linked health insur-
ance schemes
Government, healthcare organizations,
professional organizations, educational
systems, health insurance companies,
nonprofit organizations, media outlets,
technology companies, food industry,
health and fitness industry, transportation
sector, real estate companies and society
● Percent of population with ≥2.5
hours of moderate aerobic physi-
cal activity per week
● Incidence of obesity in the
population
6. Integrate mental health in the
management of chronic con-
ditions in primary care
settings
● Integrate mental health care into
national health policy using simple,
cost-effective screening tools for
depression, anxiety or stress
● Prioritize screening of mental disor-
ders in NCD patients with poorly
controlled risk factors (such as high
blood sugar, BP and BMI) or with poor
adherence, with appropriate referral
for treatment in both primary and
specialist care services
Government, professional organizations,
psychiatrists, healthcare volunteers,
psychiatrists, GPs, nurses and healthcare
workers
● Percent of ASEAN countries with
an operational integrated national
health plan with mental health risk
assessment
● Percent of patients with uncon-
trolled chronic conditions
screened for mental disorders
● Number of people screened for
mental health problems at pri-
mary care facilities
Abbreviations: ASEAN, Association of Southeast Asian Nations; BMI, body mass index; BP, blood pressure; CVD, cardiovascular diseases; GPs, general physicians; HCPs,
healthcare professionals; NCDs, noncommunicable diseases; UHC, universal health coverage
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Essential NCD Intervention (PhilPEN) protocol.45 As of
February 2017, >600,000 patients were registered under
these clubs.46 This initiative is planned to be scaled up
nationwide with the clubs also serving as community support
groups to disseminate information on adequate control of BP
and blood sugar.
Introduce Health Promotion Programs in Schools,
Universities, Workplaces, and Public Places
Regional Context
Asia had half of all overweight and obese children under
five years of age in 2014.47 A high prevalence of NCD risk
factors was observed among male and female university
Table 5 Proposed Recommendations for Addressing Gaps in Clinical and Public Health Practice for Optimizing NCD Management in
the ASEAN Member States
Recommendations Recommended Actions Potential Stakeholders Performance Indicators
1. Set up local public and private
primary care networks
● Set up primary care networks with
shared target goals, referral services and
treatment guidelines
Government and private sector,
professional organizations and HCPs
● Number of operational pri-
mary care networks deployed
in the region
2. Improve treatment adherence
using evidence-based and
innovative solutions
● Develop evidence-based digital platforms
to facilitate patient self-care, patient
communication and patient education
● Promote SDM through patient decision-
making tools and SDM training work-
shops for HCPs
Professional organizations, HCPs, nurses,
pharmacists, technology companies,
pharmaceutical sector, individuals and
caregiver
● Treatment adherence rate for
NCDs
3. Actively promote interprofes-
sional collaboration for holistic
management of NCDs
● Facilitate effective multidisciplinary treat-
ment of NCDs through joint education/
training sessions, shared document pro-
cessing platforms, clinical decision sup-
port and defined referral pathways
● Engage family members/caregivers as
peer support workers
Government, private sector, academia,
HCPs, nurses, allied health professionals,
patient and family
● Hospitalization rates due to
NCDs
● Biochemical risk factors (high
blood sugar, high BMI, high BP,
and high blood lipids)
● Number of venues available
for patients and their family’s
co-participation
4. Strengthen the role of phar-
macists and other allied health
professionals in NCD preven-
tion and care
● Build capability of pharmacists and other
allied health professionals through accre-
dited trainings to screen, counsel and
monitor NCD outcomes
● Develop specialist referral pathways for
pharmacists
Government and private sector,
professional organizations, HCPs, nurses,
pharmacists, pharmaceutical sector,
technology companies, individuals and
caregivers
● Percent of patients counselled
on their medications by phar-
macists and other allied health
professionals
● Number of trained pharma-
cists who can prescribe
medicines
● Number of pharmacies with
point-of-care NCD screening
capabilities
5. Reform health professions
education (HPE) curricula to
enhance clinical practice for
improved mental health
management
● Reorient training curricula towards iden-
tification and management of common
mental health problems for physicians,
nurses and pharmacists
● Train health workers to screen for and
identify mental health problems among
constituents in schools and colleges
Government and private sector, academia,
education board, schools and community
● Number of physicians, nurses
and pharmacists trained with
the revised curricula
● Number of trained personnel
in schools and colleges
equipped to screen for mental
health problems
6. Enhance monitoring of NCD
risk factors using evidence-
based technology
● Develop a robust national implementa-
tion framework for evidence-based
technology for health care
● Promote disease surveillance through use
of smartphone-based apps and home-
based medical devices for measuring BP,
blood sugar and BMI
● Generate and disseminate evidence on
the efficacy and effectiveness of techno-
logical solutions in improving clinical
outcomes
Government, technology companies,
pharmaceutical sector, health insurance
companies and data scientists
● Rate of premature mortality
and hospitalizations due to
NCDs among the population
using technology-based
interventions
● Percent of people with NCDs
using evidence-based technol-
ogy for health care
Abbreviations: ASEAN, Association of Southeast Asian Nations; BMI, body mass index; BP, blood pressure; HCPs, healthcare professionals; HPE, health professions
curricula; NCD, noncommunicable disease; SDM, shared decision-making.
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students from nine ASEAN member states (obesity: 28%
and 17%; low physical activity: 39% and 53%; tobacco
use: 7% and 3%) which was attributed to poor awareness
among the students.48 A study of education program on
salt intake reduction targeting school children demon-
strated positive outcomes such as decreased BP among
children and their families.49 The WHO Global Action
Plan for the prevention and control of NCDs (2013–2020)
advocates policies promoting healthy food in all public
institutions, including schools, colleges and workplaces.50
Effective implementation of such policies will help in
meeting the WHO targets related to reduction in salt
intake, halt in the rise of diabetes and obesity and reduced
prevalence of raised BP.50
Case Study
In Vietnam, 80% of salt intake comes from cooking condi-
ments rather than from processed food.51 Therefore, reducing
salt intake needs population behavior change strategies.
A behavior change program, Communication for Behavioral
Impact–Eat Less Salt (COMBI-ELS), was organized in eight
Vietnamese villages between 2013 and 2014 and included
media campaigns, school interventions and community pro-
grams focused on high-risk groups.51 Within one year, the
average salt intake reduced from 9.4 g/day to 7.4 g/day. There
was increased awareness among people on the association of
hypertension (43.6% to 86%) and stroke (9.2% to 46.6%)with
high salt intake.51 The success of this program led to imple-
mentation of a national action plan for dietary salt intake
reduction to control NCDs.
Pass and Implement Legislation to Reduce NCD
RISK Factors (Tobacco Use, Excessive Alcohol Use
and Salt Intake)
Regional Context
Growing evidence suggests that intervention strategies,
such as taxation, can effectively tackle the leading causes
of NCDs and their underlying risk factors.14,52 The popu-
lation-based “best-buys” for NCD behavioral risk factors
(tobacco, alcohol, diet, and physical activity) account for
a small fraction of the total cost of the “best buys”.14
Increasing the cost of tobacco products has the highest
impact on reducing its demand and taxes are the most
direct way to influence the cost of tobacco products.52 In
LMICs, the most cost-effective “best buy” interventions
are increased taxes on tobacco products, alcoholic bev-
erages, and sugar-sweetened beverages.14
Case Study
In 2012, the Philippine government implemented tax
reforms (“sin tax”) on all tobacco and alcohol products
to discourage smoking and consumption of excessive
alcohol.53 Comparison of tobacco use prevalence at two
time points revealed that the prevalence decreased from
30% in 2009 to 24% in 2015.54 Additionally, the average
household cigarette consumption reduced from 62 packs in
2009 to 52 packs in 2015 and evidence suggested that “sin
tax” accounted for ~70% of the actual decline in cigarette
consumption.54 A simulation study reported that updating
taxes on alcohol products may reduce alcohol consump-
tion ≤20% within four years from 2018.55 Other benefits
of the “sin tax” include increased revenue available to
fund UHC programs which could reach poor and indigen-
ous populations in geographically isolated and disadvan-
taged areas (GIDAs). The Philippines Department of
Health budget increased from USD 1.1 billion (PHP
53.2 billion) in 2013 to USD 3.2 billion (PHP
165 billion) in 2019 with “sin tax” contributing 55% of
the total budget.56 In 2018, the “sin tax” was expanded to
include sugar-sweetened drinks.57
Provide an Encouraging Physical and Social
Environment for People to Practice Healthy Habits
and Incentivize Healthy Lifestyle
Regional Context
The major modifiable risk factors for NCDs can be com-
bated, partly, by adopting a healthy lifestyle.50
Incentivizing healthy behavior can drive sustainable beha-
vioral modifications that will alleviate NCD burden.58 The
urban environment poses additional difficulty in the prac-
tice of healthy lifestyle and city dwellers are challenged
with sanitation, air pollution and access to healthy food
and safe spaces. Policies such as creating smoke-free
spaces, reducing air pollution and improving infrastructure
for walking and cycling can help create environments that
support better health outcomes. This requires collaboration
with health, transport, housing and education sectors also
referred to as the “Health-in-all polices approach”.59
Case Study
Under the Healthy Cities concept, Marikina City, Philippines
implemented several programs aimed at improving the phy-
sical and social environments supportive of health
promotion.60 Several initiatives in partnership with the pub-
lic, private and voluntary sectors of society were undertaken:
healthy streets with walkable roadways and extensive
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bicycle network, healthy markets which are clean, accessible
and have food testing facilities, healthy schools with
a healthy feeding program and free health checkups condu-
cive for learning among others. Since 2004, Marikina City
has received various awards, including one from the WHO,
for “Outstanding Healthy City”.60 The City of Marikina was
one of the founding members of the WHO Alliance for
Healthy Cities initiative established in 2003.
Integrate Mental Health in the Management of
Chronic Conditions in Primary Care Settings
Regional Context
The treatment gap, or the difference between the number of
people needing care vs those receiving care, ranges from 50–
90% for mental disorders in the ASEAN region.61 Close
links between NCDs and mental disorders, particularly CVD
and depression, are well established.2,62 Patients with psy-
chiatric comorbidities have longer treatment duration and
poor outcomes.2 Despite this evidence, cardiovascular risk
assessment does not include depression.62 Given the over-
lapping risk factors between mental disorders and other
NCDs, integrated management of both conditions can
reduce the associated disability.2 The lack of primary care
facilities, policy implementation and trained health workers
together with the associated stigma hinder access to mental
health treatment.63 Simple and cost-effective tools such as
Patient Health Questionnaire-2 for mental health screening
and the WHO Package of Essential Noncommunicable
Disease Interventions can be easily deployed in low-
resource primary care settings to reduce NCD risk
factors.64,65 Integrating mental health treatment into the
NCD collaborative care model in LMICs has demonstrated
improvement in quality of care and patient outcomes.66
Case Study
In 2008, Thailand had an estimated 1.5 million people with
depression and the rate of suicide was six per 100,000
population.67 The Surveillance System of Depressive
Disorders (SDDP) set up in 2006 was the first nationwide
mental health program in Thailand with a framework for
depression intervention focused on awareness, training,
research, and national health policy advocacy.67 Simple
instruments for screening at-risk populations and prevent-
ing relapse and clinical practice guidelines for primary care
were developed as part of the program. Until 2016,
>14 million people were screened and received mental
health education.67 Access to services for depressive
disorders increased from 5.1% in 2009 to 48.5% in 2016
across public health services.67
Theme 2: Addressing NCD Clinical and
Public Health Practice Gaps in the
ASEAN Region
Set Up Local Public and Private Primary Care
Networks
Regional Context
As the most frequent entry point for patients, primary care
has the greatest potential to screen and identify high-risk
patients. Efficient use of limited healthcare facilities and
human resources, sustainable health financing mechan-
isms, access to basic diagnostics, essential medicines,
organized medical information and effective referral sys-
tems are imperative to ensure an equitable primary health-
care in LMICs.65
Case Study
It is estimated that a quarter of all adult Thais have
hypertension and only one-third have their BP under
control.68 Despite extensive screening, about half of all
patients remain undiagnosed due to patient or health sys-
tems factors.68 The public sector accounts for >70% of
health facilities in Thailand.69 The Government of
Thailand included free screening, diagnosis, treatment
and laboratory monitoring for hypertension to everyone
within the primary healthcare system as part of UHC, in
2002.69 Some of the best practices for providing hyperten-
sion care includes a unique identification card to maintain
electronic health record and facilitate follow-up for every
patient, opportunistic screening at every outpatient visit,
patient-centric care provided closer to home, functional
referral linkages, regular drug supply and 3-month pre-
scriptions, and availability of dedicated team of well-
trained staff at all levels.69 In 2019, 88% of all eligible
Thai population had their BP screened at the community
level.69 Each month about 50,000–70,000 new cases are
diagnosed from all public health facilities and BP control
has doubled from 24% in 2004 to 50% in 2014.69 About
80% of patients received treatment within reasonable dis-
tance (~7 km) from their homes, in 2019.69 To further
increase access to screening, diagnosis and treatment of
hypertension for the working population, measures to
reduce diagnostic and treatment inertia and collaboration
with the private sector are proposed.
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Improve Treatment Adherence Using Evidence-Based
and Innovative Solutions
Regional Context
Adherence denotes active participation of patients in their
therapeutic plan, whereas compliance suggests passively fol-
lowing the plan.70 Medication adherence is influenced by the
patient, disease condition, therapy, healthcare ecosystem and
socioeconomic factors. Adherence to antidepressants
remains as low as 60% within 6 months of starting
treatment.71 Collaborative care approach where each profes-
sional contributes towards the patient journey by providing
multiple opportunities to receive critical messages can be
instrumental in improving adherence. Nonadherence to anti-
depressants is strongly associated with patients’ perceptions
of their relationships with HCPs, including a lack of shared
decision-making (SDM) or trust.72 Lack of a structured flow,
time and patient aids are the key challenges faced by doctors
in implementing SDM. The biopsychosocial model of care
emphasizes patient centricity as the guiding principle to
strengthen “therapeutic alliance” and medication adherence.
Case Study
The SDM concept was introduced in Malaysia in 2010.
Despite government efforts to promote patient-centricity in
decision-making, SDM lacks widespread implementation.73
A shared/collaborative role in decision-making is preferred
by Malaysian patients in urban setting (51%), 28% in rural
setting and 32% of adolescents.73 A focus group study invol-
ving 19 psychiatrists and 11 patients with major depressive
disorder was conducted at an urban teaching hospital in
Malaysia to develop a strategic tool for SDM in the use of
antidepressants.74 The tool included a booklet of scripts for
doctors which was adapted from the “Elwyn’s three-talk
model of shared decision-making” and a patient decision
aid prior to “team talk”.75 The model depicts conversational
steps, initiated by providing support when introducing
options, followed by strategies to compare and discuss trade-
offs, before deliberation based on informed preferences.75
Actively Promote Interprofessional Collaboration for
Holistic Management of NCDs
Regional Context
Interprofessional collaboration is the coordinated care of
patients by a team of HCPs, which is interactive, additive
and holistic in nature.76 Patients with NCDs frequently
have multiple, comorbid long-term conditions requiring
holistic treatment. Collaborative care integrates patients
and families in the healthcare delivery system resulting
in higher treatment satisfaction, compliance and treatment
performance.77 Patients who have recovered or are reco-
vering can be trained as peer support specialists to form
part of multidisciplinary treatment teams. The major bar-
riers to implementing a collaborative care approach are
a lack of understanding of roles and responsibilities for
different team members, lack of confidence in the benefits
of interprofessional care, and inertia of traditional practice
(“health care silos”).76 Collaborative care can be supported
by joint education sessions, shared document processing
and appointments, and incentives.
Case Study
In 2005, Asia had the highest number people with dia-
betes, with a disproportionate increase in diabetes among
the young and middle-aged population.78 Protocol-driven
multidisciplinary care reduced the risk of clinal outcome
by 50–70% in diabetes vs standard care.78 Joint Asia
Diabetes Evaluation (JADE) was set up in 2007 as the
first web-based collaborative program to improve ambula-
tory diabetes care and implemented in Taiwan, Singapore,
Thailand, and Philippines among other countries. JADE
incorporated a validated risk engine, evidence-based care
protocol, clinical decision support and personalized report-
ing to support team-based integrated care.78 Importantly,
JADE e-portal is utilized by health care teams to create
diabetes registry to detect defaults, monitor clinical pro-
gress and track performance indices of patients for con-
tinuous quality improvement.78 Implementation of JADE
is estimated to lower hospitalization rates by 20–50% and
reduce healthcare costs by USD 242/patient/year (HKD
1,876/patient/year) compared with standard care.79,80
Strengthen the Role of Pharmacists and Other Allied
Health Professionals in NCD Prevention and Care
Regional Context
The WHO emphasizes the important role of pharmacies in
the primary healthcare network to provide early screening
and testing, advanced counselling and long-term chronic
disease management.81 As the most accessible primary
HCPs, community pharmacists remain an integral part of
the multidisciplinary team for optimizing NCD care.
Pharmacists are ideally placed to implement public health
programs, lead point-of-care NCD screening programs,
improve patients’ adherence, educate patients and care-
givers on disease management, and assist in medication
review and correct use of devices.81
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Case Study
Increasing healthcare costs and an ageing population in
Singapore needs evolved pharmacy services to meet the
increasing healthcare burden and provide cost-effective
health care.82 The National Pharmacy Strategy is a 10-
year national plan by Singapore Ministry of Health to
transform the pharmacy profession.82 The initiative has
a focus on five key areas: enhancing pharmacy-led value-
based healthcare services to the community; restructuring
training and education programs for a skilled pharmacy
workforce; redesigning a seamless, accessible and afford-
able supply chain for medication delivery at every point-of
-care; providing information-sharing platform for clinical
and practice-based research; and enabling technology to
deliver care across settings.82 Under this strategy, the
National University of Singapore launched a National
Collaborative Prescribing Programme in 2018 to train
senior pharmacists and advanced practice nurses so they
may independently prescribe medicines and order tests for
patients.83
Reform Health Professions Education (HPE)
Curricula to Enhance Clinical Practice for Improved
Mental Health Management
Regional Context
In the ASEAN region, only 30% of the countries provide
mental health training to primary care doctors and only
half of the countries have officially approved training
manuals in most primary healthcare clinics.84 WHO, with
an aim to close the mental health treatment gap, recom-
mends integrating mental health services into primary
health care, which can be accomplished by reforming the
mental health training.85 The stigma associated with men-
tal disorders prevents adolescents and their guardians from
seeking help at psychiatric hospitals or mental health cen-
ters. Altogether, training primary care doctors and school-
teachers and staff in suicide prevention is a top priority to
recognize at-risk adolescents and get them further
counselling.
Case Study
Singapore reported a six-fold rise in adolescent psychiatric
cases between 1980 and 2000.86 In 2010, mental disorders
were the largest contributor of disability among children <15
years old in Singapore.86 Response, Early Intervention and
Assessment in Community Mental Health (REACH) is
a collaborative program launched in 2007 by the Singapore
Ministry of Education, Institute of Mental Health and two
other hospitals to implement mental health services in all
registered schools.86 The program aimed to increase acces-
sibility of mental health support to at-risk students by enhan-
cing the capacity of schools with trained personnel to support
these students and building community support networks.
Between 2007 and 2015, 4184 students were referred to
REACH by school counsellors; 955 of these students were
referred to tertiary care. Within six months, the clinical out-
come of the students improved as assessed by counsellors/
teachers.86 REACH, a community-based care program, was
more cost-effective than hospital-based care.86
Enhance Monitoring of NCD Risk Factors Using
Evidence-Based Technology
Regional Context
Increasing smartphone usage accompanied with decreas-
ing device and telecommunication service prices offer
cost-effective opportunities for e-health and m-health tech-
nologies in resource-constrained economies. Information
and communication technologies can transcend geographic
barriers between patients and physicians—facilitating
patient communications, enhancing diagnoses and treat-
ments, improving data management, streamlining financial
transactions and preventing counterfeit medicine supply.87
However, there is a dearth of high-quality scientific evi-
dence for the clinical benefits of technology-based health
monitoring apps which needs to be overcome.
Case Study
In 2016, CVD accounted for a third of all deaths in
Indonesia.88 The government developed a policy for pre-
venting and managing CVD through advocacy, health
promotion, and health system strengthening particularly
at district health agencies. Systematic Medical Appraisal
Referral and Treatment (SMARThealth)—a multifaceted
mobile technology-supported primary healthcare interven-
tions was evaluated in populations from eight rural vil-
lages in Indonesia.88 The mobile application enabled
primary healthcare nurses and physicians and community
healthcare workers to collect patient information using
basic equipment, assess individuals’ risk status, receive
tailored decision support, provide lifestyle advice and
refer high-risk individuals to nurses and physicians. Use
of SMARThealth interventions led to a significantly
greater proportion of high-risk rural Indonesian population
achieving systolic BP target <140 mmHg than those with-
out the intervention (31.0% vs 22.2%, adjusted relative
risk 1.3; 95%CI: 1.2–1.5; p<0.001).88 These effects were
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driven by a greater use of preventive CVD medications
among high-risk individuals receiving SMARThealth
interventions compared with individuals without the inter-
vention (56.8% of individuals in the intervention villages
used BP medication vs 15.7% of individuals in the control
villages).88
Discussion
Most (73%) Southeast Asian countries have treatment guide-
lines for the four major NCDs (CVD, diabetes, cancers, and
chronic respiratory diseases).89 All 11 countries from the
Southeast Asian region also have a national NCD policy/
strategy/action plan, though the integrated plan is operational
in only 80% of the countries in the region.89 These variations
in NCD policy implementation influence the national capa-
city of healthcare systems to effectively tackle NCDs. The
most widespread policy gaps in the region are inadequate
surveillance of NCDs and their risk factors, suboptimal
health insurance coverage, lack of trained healthcare person-
nel and limited primary care capacity.6,90 Addressing gaps in
NCD prevention and management in the ASEAN member
states requires innovative multisectoral public–private part-
nerships, “whole-of-government” approach, “whole-of-
society” approach and “health-in-all policies” to provide
cost-effective, efficient and quality health services (Table
4).91 Participation of citizens remains integral to these efforts
in filling the lacunae in NCD management. Awareness of
NCD risk factors and mental health management should be
introduced at an early age to help imbibe optimal practices to
prevent the rise in NCDs.
Countries in the ASEAN region rely both on public
and private primary healthcare services for NCD care
delivery.92 Most ASEAN member states have integrated
the basic management of the four major NCDs into pri-
mary health care. However, the existing primary health
care systems lack the capacity to consistently provide
essential preventive interventions for NCDs, long-term
chronic care for NCDs and associated comorbidities, and
adequate mental health management services.93,94 The
acute shortage of human resources and treatment facilities
for mental health in Southeast Asian countries combined
with low rates of overall medication adherence in Asian
populations further contribute to the NCD treatment gap.94
The proposed solutions for addressing clinical and public
health practice gaps in NCD management require strength-
ening primary care services, employing collaborative care
approach, expanding the roles of primary care HCPs and
pharmacists, and developing technology-based based
healthcare solutions (Table 5). Population-based and clin-
ical approaches to prevent NCDs need to be prioritized
both in urban and rural areas.93
In 2013, the ASEAN member states adopted the Bandar
Seri Begawan Declaration on NCDs in ASEAN.95 The
declaration highlighted the need to accelerate actions to
reduce NCDs through engagement of multiple stakeholders
including the private sector, intensification of NCD screening
and health promotion activities, strengthening health systems
capacity, enhancing efforts toward achieving the WHO
voluntary targets for NCD prevention and control, advancing
UHC and adopting health-in-all policies.95 At a subsequent
meeting in 2017, the ASEAN member states renewed their
commitment to the declaration while highlighting the rising
prevalence of NCDs and their risk factors as well as the
interventions and best practices implemented by the member
states to prevent risk factors and promote health through the
delivery of relevant health services.96
NCD care must move towards an interprofessional, col-
laborative, transdisciplinary approach with seamless sharing
of knowledge and decision-making to improve effectiveness
and efficiency in NCD care.97 Inclusion of patients, their
families and communities is vital to a successful continuum
of NCD care.97 It is encouraging to note the overlap between
the recommendations from this paper and the recent recom-
mendations from an independent WHO high-level commis-
sion including empowering individuals by providing health
promoting environment, incorporating NCDs and mental
health as essential components of UHC and partnering with
businesses to mount effective NCD responses.98
Study Limitations
There are several limitations to our study. First, though the
ASEAN region comprises 10 countries, our recommenda-
tions were based on insights from experts representing six
ASEANmember states (~95% of the ASEAN population).99
Second, the case studies presented in this paper were pro-
vided by selected experts from the region and located via
literature search. However, there may be other successful
case studies in the region which are not reported here. The
case studies showed good practices which need to be con-
textualized within the local culture and health care settings
of respective countries and further validated for implemen-
tation in another country. Some of the case studies have not
shown definitive measures of improvement in clinical or
cost-effectiveness outcomes; and such outcomes still need
to be determined. Lastly, while this paper focuses on cardi-
ovascular and mental disorders, these recommendations
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maybe extended to other NCDs such as diabetes, cancer and
chronic respiratory diseases as the NCD risk factors tend to
cluster together.2
Conclusion and Future Directions
Identifying implementation challenges and proposing solu-
tions for national and local NCD planning requires
a multistakeholder approach, which was addressed in this
study, partly, by engaging a multidisciplinary expert group.
Further operationalization of the recommendations included
in this paper requires commitment and participation from
other stakeholders such as policy makers.100 The implemen-
tation of NCD programs can be supported through public–
private partnerships; however, successful partnerships need
an established regulatory framework and clearly outlined
goals.101 Evidence-based digital technologies have the
potential to improve care coordination, prevent hospitaliza-
tions and reduce health wastage.102 Technologies such as
artificial intelligence have shown promise in assisting clin-
ical decision support, however these digital solutions need to
be rigorously evaluated for safe and effective as well as
ethical integration.103 Further research on patient beliefs
and health-seeking behavior in low-income settings and
their effect on healthy lifestyle can help tailor more effective
NCD prevention programs for the ASEAN region.104,105
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